Literature DB >> 1151419

Mitogen and muscle extract induced in vitro proliferative responses in myasthenia gravis, dermatomyositis, and polymyositis.

R P Lisak, B Zweiman.   

Abstract

We have compared the lymphocyte in vitro proliferative response induced by muscle extract, phytohaemagglutinin, and pokeweed mitogen in peripheral blood lymphocytes of patients with myasthenia gravis, polymyositis, dermatomyositis, and normal subjects. Similar mean responses to antigen and mitogen were seen in cells of all groups of patients. The proliferative responses induced by muscle did not differ in thymic cells from myasthenics as compared with those from cardiac surgery controls. Our findings do not support the hypothesis that cell-mediated immunity to muscle or major impairment of lymphocyte responses to mitogens occurs in these diseases.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1151419      PMCID: PMC492021          DOI: 10.1136/jnnp.38.6.521

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Thymic lymphocyte function in myasthenia gravis.

Authors:  R M Armstrong; R M Nowak; R E Falk
Journal:  Neurology       Date:  1973-10       Impact factor: 9.910

Review 2.  Immunologic significance of in vitro lymphocyte responses.

Authors:  F Daguillard
Journal:  Med Clin North Am       Date:  1972-03       Impact factor: 5.456

3.  Studies in myasthenia gravis: cellular hypersensitivity to skeletal muscle.

Authors:  L I Alpert; A Rule; M Norio; E Kott; P Kornfeld; K E Osserman
Journal:  Am J Clin Pathol       Date:  1972-12       Impact factor: 2.493

4.  The thymus in myasthenia gravis. Evidence for altered cell populations.

Authors:  N I Abdou; R P Lisak; B Zweiman; I Abrahamsohn; A S Penn
Journal:  N Engl J Med       Date:  1974-12-12       Impact factor: 91.245

5.  Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders.

Authors:  M M Esiri; I C MacLennan; B L Hazleman
Journal:  Clin Exp Immunol       Date:  1973-05       Impact factor: 4.330

6.  Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression.

Authors:  R L Dawkins; F L Mastaglia
Journal:  N Engl J Med       Date:  1973-03-01       Impact factor: 91.245

7.  Cell-mediated immunity in polymyositis. Creatine phosphokinase release from muscle cultures.

Authors:  D C Haas; B G Arnason
Journal:  Arch Neurol       Date:  1974-09

8.  Sensitized lymphocytes in muscular dystrophy: evidence for a neural factor in pathogenesis.

Authors:  E A Caspary; S Currie; E J Field
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-06       Impact factor: 10.154

Review 9.  In vitro approaches to the mechanism of cell-mediated immune reactions.

Authors:  B R Bloom
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

10.  Delayed hypersensitivity to muscle and thymus in myasthenia gravis and polymyositis.

Authors:  J M Goust; A Castaigne; R Moulias
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

View more
  8 in total

1.  Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis.

Authors:  W M Behan; P O Behan; J A Simpson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-11       Impact factor: 10.154

Review 2.  Cellular autoimmunity to muscle: a review.

Authors:  M Esiri
Journal:  Proc R Soc Med       Date:  1977-05

Review 3.  Immunological features of polymyositis/dermatomyositis.

Authors:  W M Behan; P O Behan
Journal:  Springer Semin Immunopathol       Date:  1985

Review 4.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985

Review 5.  Recent advances in polymyositis.

Authors:  W M Behan; P O Behan
Journal:  Ital J Neurol Sci       Date:  1984-03

6.  Clinical and immunological associations in myasthenia gravis. 2. Cell-mediated immunity.

Authors:  H J Sagar; G A Davies-Jones; I D Allonby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154

7.  Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders.

Authors:  W M Behan; P O Behan; D Doyle
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

8.  Lymphocyte function in myasthenia gravis.

Authors:  S Kawanami; A Kanaide; Y Itoyama; Y Kuroiwa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-08       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.